1.
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population
by Schuur, M
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.41-4
2.
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
by Talmud, Philippa J
American journal of human genetics, 2009-11-13, Vol.85 (5), p.628-642
3.
Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol
by Schmidt, Ellen M
American journal of human genetics, 2014-02-06, Vol.94 (2), p.233-245
4.
PET Imaging of Tau Deposition in the Aging Human Brain
by Schöll, Michael
Neuron (Cambridge, Mass.), 2016-03-02, Vol.89 (5), p.971-982
5.
Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population
by Licher, Silvan
Nature medicine, 2019-09, Vol.25 (9), p.1364-1369
6.
American Medical Society for Sports Medicine position statement: concussion in sport
by Harmon, Kimberly G
British Journal of Sports Medicine, 2013-01, Vol.47 (1), p.15-26
7.
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
by Cruchaga, Carlos
Neuron (Cambridge, Mass.), 2013-04-24, Vol.78 (2), p.256-268
8.
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
by Rannikmäe, Kristiina
Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.300-305
9.
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
by Panjwani, Naim
Endocrinology (Philadelphia), 2013-01, Vol.154 (1), p.127-139
10.
Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases
by Kovacs, Gabor G
Journal of neuropathology and experimental neurology, 2017-04-01, Vol.76 (4), p.270-288
11.
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE−/− mice fed a western diet
by Han, Ji Hye
Diabetologia, 2016-11-19, Vol.60 (2), p.364-376
12.
The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes
by Cenarro, Ana
The journal of clinical endocrinology and metabolism, 2016-05, Vol.101 (5), p.2113-2121
13.
Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by Ward, Alex
Neuroepidemiology, 2012-01, Vol.38 (1), p.1-17
14.
Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective
by Cherepanova, Olga A
Nature medicine, 2016-06, Vol.22 (6), p.657-665
15.
Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study
by Lee, Alexandra K
Diabetologia, 2018-06-30, Vol.61 (9), p.1956-1965
16.
DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease
by Shao, Yvonne
Journal of human genetics, 2018-04, Vol.63 (4), p.459-471
17.
Regulatory T Cells Prevent Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E Knockout Mice
by Meng, Xiao
Hypertension (Dallas, Tex. 1979), 2014-10, Vol.64 (4), p.875-882
18.
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
by Ervinna, Nasib
Endocrinology (Philadelphia), 2013-03, Vol.154 (3), p.1260-1270
19.
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
by Ringman, John M
Journal of neuropathology and experimental neurology, 2016-03, Vol.75 (3), p.284-290
20.
Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
by Colom-Cadena, Martí
Journal of neuropathology and experimental neurology, 2013-12, Vol.72 (12), p.1203-1212
